Literature DB >> 24045975

Increased lipid synthesis and decreased β-oxidation in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model of metabolic syndrome.

Shizuyo Tanaka1, Tohru Yamazaki, Satoshi Asano, Atsushi Mitsumoto, Daisuke Kobayashi, Naomi Kudo, Yoichi Kawashima.   

Abstract

SHR/NDmcr-cp (cp/cp) rats (SHR/NDcp) are an animal model of metabolic syndrome. A previous study of ours revealed drastic increases in the mass of palmitic (16:0), oleic (18:1n-9), palmitoleic (16:1n-7), cis-vaccenic (18:1n-7) and 5,8,11-eicosatrienoic acids in the liver of SHR/NDcp. However, detailed information on the class of lipid accumulated and the mechanism responsible for the overproduction of the accumulated lipid in the liver was not obtained. This study aimed to characterize the class of lipid accumulated and to explore the mechanism underlying the lipid accumulation in the liver of SHR/NDcp, in comparison with SHR/NDmcr-cp (+/+) (lean hypertensive littermates of SHR/NDcp) and Wistar Kyoto rats. In the liver of SHR/NDcp, de novo synthesis of fatty acids (16:0, 18:1n-9 and 16:1n-7) and triacylglycerol (TAG) synthesis were up-regulated and fatty acid β-oxidation was down-regulated. These perturbations of lipid metabolism caused fat accumulation in hepatocytes and accumulation of TAG, which were enriched with 16:0, 18:1n-9 and 16:1n-7, in the liver of SHR/NDcp. On the other hand, no changes were found in hepatic contents of diacylglycerol and unesterified fatty acid (FFA); among FFA, there were no differences in the hepatic concentrations of unesterified 16:0 and stearic acid between SHR/NDcp and two other groups of rats. Moreover, little change was brought about in the expression of genes responsive to endoplasmic reticulum stress in the liver of SHR/NDcp. These results may reinforce the pathophysiological role of stearoyl-CoA desaturase 1 and fatty acid elongase 6 in the liver of SHR/NDcp.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045975     DOI: 10.1007/s11745-013-3839-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  66 in total

1.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

2.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 3.  Acyl-CoA:diacylglycerol acyltransferase: molecular biology, biochemistry and biotechnology.

Authors:  Qin Liu; Rodrigo M P Siloto; Richard Lehner; Scot J Stone; Randall J Weselake
Journal:  Prog Lipid Res       Date:  2012-06-15       Impact factor: 16.195

4.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.

Authors:  Jiang Wei Wu; Shu Pei Wang; Fernando Alvarez; Stéphanie Casavant; Nicolas Gauthier; Lynda Abed; Krishnakant G Soni; Gongshe Yang; Grant A Mitchell
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

6.  A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.

Authors:  Maja Stefanovic-Racic; German Perdomo; Benjamin S Mantell; Ian J Sipula; Nicholas F Brown; Robert M O'Doherty
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-18       Impact factor: 4.310

7.  Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.

Authors:  Marc Issandou; Anne Bouillot; Jean-Marie Brusq; Marie-Claire Forest; Didier Grillot; Raphaelle Guillard; Sandrine Martin; Christelle Michiels; Thierry Sulpice; Alain Daugan
Journal:  Eur J Pharmacol       Date:  2009-07-17       Impact factor: 4.432

8.  Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes.

Authors:  O E Michaelis; K C Ellwood; J M Judge; N W Schoene; C T Hansen
Journal:  Am J Clin Nutr       Date:  1984-04       Impact factor: 7.045

9.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Toyonori Kato; Ayaka Atsumi; Takashi Yamamoto; Noriyuki Inoue; Mayumi Ishikawa; Sumiyo Okada; Naomi Ishigaki; Hitoshi Iwasaki; Yuko Iwasaki; Tadayoshi Karasawa; Shin Kumadaki; Toshiyuki Matsui; Motohiro Sekiya; Ken Ohashi; Alyssa H Hasty; Yoshimi Nakagawa; Akimitsu Takahashi; Hiroaki Suzuki; Sigeru Yatoh; Hirohito Sone; Hideo Toyoshima; Jun-ichi Osuga; Nobuhiro Yamada
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

10.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.

Authors:  Yun Wang; Daniela Botolin; Jinghua Xu; Barbara Christian; Ernestine Mitchell; Bolleddula Jayaprakasam; Muraleedharan G Nair; Muraleedharan Nair; Jeffrey M Peters; Jeffery M Peters; Julia V Busik; Julia Busik; L Karl Olson; Donald B Jump
Journal:  J Lipid Res       Date:  2006-06-21       Impact factor: 5.922

View more
  2 in total

1.  Abnormalities in the Metabolism of Fatty Acids and Triacylglycerols in the Liver of the Goto-Kakizaki Rat: A Model for Non-Obese Type 2 Diabetes.

Authors:  Minako Karahashi; Yuko Hirata-Hanta; Kohei Kawabata; Daisuke Tsutsumi; Misaki Kametani; Nanako Takamatsu; Takeshi Sakamoto; Tohru Yamazaki; Satoshi Asano; Atsushi Mitsumoto; Yoichi Kawashima; Naomi Kudo
Journal:  Lipids       Date:  2016-07-02       Impact factor: 1.880

2.  Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial.

Authors:  Karin E Koopman; Matthan W A Caan; Aart J Nederveen; Anouk Pels; Mariette T Ackermans; Eric Fliers; Susanne E la Fleur; Mireille J Serlie
Journal:  Hepatology       Date:  2014-05-13       Impact factor: 17.425

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.